GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Ocular Therapeutix OCUL · USD

Health Care · US listing · 🇺🇸 United States

Compare

6.85

+3.79%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Largest shareholders

As filed, so dates differ, and a group and its funds can both appear.

HolderSharesStakeChangeFiled
FMR LLC32.7m15.00%+868.2k31 Mar 2026
DEEP TRACK CAPITAL, LP19.7m9.04%+11.6m31 Mar 2026
BLACKROCK, INC.16.1m7.41%+530.5k31 Mar 2026
AVORO CAPITAL ADVISORS LLC12.3m5.66%+1.5m31 Mar 2026
SUMMER ROAD LLC11.9m5.46%+771.3k31 Mar 2026
VR ADVISER, LLC10.3m4.75%+3m31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC8.7m4.01%+8.7m31 Mar 2026
PRICE T ROWE ASSOCIATES INC /MD/5.9m2.71%+5.7m31 Mar 2026
POINT72 ASSET MANAGEMENT, L.P.5.5m2.54%+4.5m31 Mar 2026
STATE STREET CORP4.7m2.16%+512.1k31 Mar 2026
GEODE CAPITAL MANAGEMENT, LLC4.5m2.08%+172.6k31 Mar 2026
ALLIANCEBERNSTEIN L.P.4.1m1.90%−212.3k31 Mar 2026
LOGOS GLOBAL MANAGEMENT LP3.9m1.77%+350k31 Mar 2026
OCTAGON CAPITAL ADVISORS LP3.2m1.45%+543k31 Mar 2026
BALYASNY ASSET MANAGEMENT L.P.2.7m1.24%+1.9m31 Mar 2026

Insider trades

Purchases and sales by directors and officers, as filed with the regulator

DateWhoTypeSharesPriceValue
23 Feb 2026 ↗Heier Jeffrey S.Chief Scientific OfficerSale3.1k8.28$25,312
23 Feb 2026 ↗Nayak SanjayChief Strategy OfficerSale1.8k8.28$14,565
23 Feb 2026 ↗Dugel PravinSee RemarksSale20.1k8.28$166,064
23 Feb 2026 ↗Kaiser PeterChief Development OfficerSale2.8k8.28$23,267
20 Feb 2026 ↗LINDSTROM RICHARD L MDDirectorPurchase60.2k7.66$461,354
20 Feb 2026 ↗Waheed NadiaChief Medical OfficerSale3.5k7.74$27,167

Short interest

Shares sold short, 15 Oct 2026. US exchange data.

28.8m

-2.2% on the period before. 8.1 days to cover.

Short volume

Share of the day's trading sold short, 4 Nov 2026

44.0%

Last 60 trading days.

Failed deliveries

Shares not delivered on settlement, from the SEC

  • 24 Sept 202618,920 shares
  • 11 Sept 202623,695 shares
  • 10 Sept 202613,740 shares
  • 2 Sept 202698,376 shares
  • 1 Sept 202626,960 shares

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.